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ABSTRACT   
We report a broadband time-resolved characterization of selected bony prominence locations of the human body. A 
clinical study was performed at six different bony prominence locations of 53 subjects. A portable broadband time-
resolved system equipped with pulse drift and distortion compensation strategy was used for absorption and scattering 
measurements. Key tissue constituents were quantified as a pilot step towards non-invasive optical assessment of bone 
pathologies. 
Keywords: time-resolved spectroscopy, scattering, absorption, osteoporosis, bone, calcaneus, in-vivo, biomedical.  
1. INTRODUCTION  
Bone is subject to continuous change in response to loading caused by our daily activities. Remolding and damage 
caused by loading affect tissue composition1. Non-invasive observation of physiological conditions of bone can predict 
pathologies related to bone. Classification of human and mammal bone is made on the bases of its porosity and 
microstructure2 and it is of two types. The first dense cortical bone with porosity 5% to 10% is termed compact bone is 
commonly found in the shaft of long bones. The second spongy, more porous (50% to 90%) bone is termed trabecular or 
spongy bone. It is commonly found at the extremities of long bones or in flat bones as for example the pelvis or the 
sternum.  
Dual X-ray Absorptiometry (DEXA) scan3 is applied on trabecular bone and is the gold standard to assess bone mineral 
density (BMD). The T-score is also used to characterize bone constitution.  It is given by DEXA scans and can assess 
age independent degradation of bone. T-score of -1 to -2.5 and below -2.5 corresponds to osteopenia and osteoporosis 
conditions, respectively4. However, DEXA suffers from the invasiveness caused by the use of ionizing radiation. 
Ultrasound based techniques provide mainly structural and morphological information, but fail in judging precisely the 
physiological status of the bone5. Several other tests like x-ray scattering6 methods or Magnetic Resonance Imaging 
(MRI) based bone mineral discrimination have been reported, but all show limitations that prevent wide and effective 
application. 
Previously, diffuse optical techniques were used to characterize bone tissue7. In reference to the problem of osteoporosis, 
interesting results were reported by light scattering techniques showing correlation between osteoporosis and bone 
scattering coefficient8. Preliminary in vivo optical measurements on 5 volunteers done on calcaneous bone9 showed 
interesting correlation between age, various tissue constituents (lipid, collagen, hemoglobin) and the scattering 
coefficient using a time-resolved broadband laboratory-based system10 Bone fibrous tissue structure consists of 
connective tissue, proteins (mostly collagen) and blood cells as major components. The concentration of collagen and 
other tissue constituents could be related to bone physiological condition and to alterations induced by pathologic 
conditions. 
In our current work, we used a time-resolved diffused optical technique to measure in vivo broadband (600-1200 nm) 
optical properties in 6 different locations of 53 subjects. As the pathological changes are revealed early in the trabecular 
bones, we choose the distal and proximal extremities of ulna and radius in the arm trochanter in reflectance and 
calcaneous in transmittance for our studies. All these locations except the calcaneous were  scanned with DEXA. 
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2. MATERIALS AND METHODS 
2.1 System setup  
A schematic diagram depicting the optical chain of the portable time-resolved system is shown in Fig. 1. The source is 
provided by a photonic crystal based supercontinuum fiber laser (SC450, Fianium,UK) with 6 W overall power over a 
spectral range 450-1750 nm. The pulses of width of few picoseconds are generated at a 40 MHz repetition rate. Spectral 
tunability is achieved by dispersing the source with a Pellin-Broca prism and coupling the selected wavelength into an 
optical fiber. To achieve higher responsivity, two different detectors, a Hamamatsu Silicon Photomultiplier (SiPM) 
possessing better temporal resolution(133ps) than the previously reported SiPM detector based time resolved invivo 
study11 and Hamamatsu InGaAs PMT, are used over their corresponding efficient spectral regions. A pellicle beam 
splitter is used to change detector at desired wavelength. The system was designed to work efficiently over the range of 
600-1200 nm. A reference line acquiring the instrument response function (IRF) synchronously with the signal is added 
with delay to optical chain to compensate for shape distortion in real time in a clinical environment. The probe consists 
of two slots to fix source and detector fibers and detachable foam, which is sterilized before each measurement. 
Reflectance measurements were done at 2.5 cm as source detector separation. 
 
Fig. 1: Block diagram of system used in measurement (left) and bone prominence locations measured in the protocol (right) 
2.2 Measurement Protocol  
The study population consists of 53 subjects distributed over the age of 20 to 78 years, who were enrolled into the 
protocol with signed informed consent. The subjects were asked to fill in a basic health questionnaire regarding their 
history of anemia, lung disease, coronary artery disease, smoking etc. Blood pressure, oxygen saturation and pulse rate 
were measured before and after the optical measurement, ensuring an overall healthy condition for the subjects. 
Measurements at radius distal, radius proximal, ulna distal, ulna proximal were done by keeping the subject’s hand in a 
comfortable position. For the trochanter location, measurements were performed by asking subjects to stand up and to 
lean gently on the ipsilateral side to expose further the bone. A customized probe ensuring a perfect transmittance 
geometry was used for calcaneus measurement. DEXA scans were taken for each subject in all locations except for the 
calcaneous. 
 
3. DATA ANALYSIS 
3.1 Evaluation of time-resolved optical data 
Absorption (μa) and reduced scattering (μ's) coefficients were estimated by fitting experimentally acquired curves at each 
wavelength with an analytical solution of the diffusion approximation to the transport equation for a homogeneous semi-
infinite medium or an infinite slab12. Extrapolated boundary conditions were used. Theoretically predicted curves were 
convolved with acquired IRF and normalized to the experimentally acquired curve. 80% of peak value on the rising edge 
of the curve and 1% on the tail were chosen as the limits of the fitting range13.  
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3.2 Secondary fit 
The percentage quantification of the key tissue constituents was performed by fitting the absorption spectra with a linear 
combination of the main tissue constituents (lipid, water, collagen, oxy-hemoglobin, deoxy- hemoglobin) spectra14. The 
absorption coefficient at each wavelength is given by the equation: 
μa(λ) = ∑i ci εi(λ) 
where λ is the wavelength of light, ci and εi are the concentration (free fit parameter) and the specific absorption of the ith  
component, respectively.  
The wavelength dependence of the scattering spectra can be approximated by a power law derived empirically from the 
Mie theory15as:  
μ,s = a(λ/λ0)-b  
for a certain fixed wavelength λ0. The exponent b is related to the mean effective size of scattering centers, while the 
amplitude a is related to the density of the scattering centers8. 
 
4. RESULTS AND CONCLUSION 
Figure 2 shows the sample broadband absorption spectra of a subject at the 6 different locations measured in the 
protocol. The solid line displays the absorption of the linear combination of key tissue constituents estimated by the 
secondary fitting procedure, while the dots are the broadband absorption values extracted by the diffusion model. The 
estimated absorption properties can vary significantly from case to case both at short wavelengths (where blood 
absorption is dominant) and on the absorption peaks of lipids at 930 nm and water around 980 nm.  
                        Figure 2: Broadband absorption spectra of 6 locations measured in the protocol. 
 
Table 1 gives the quantified values of tissue constituents (lipid, water, collagen, oxy-,deoxy-hemoglobin, abbreviated 
HbO2 and Hb), total hemoglobin concentration (tHb) and tissue oxygen saturation (StO2) at the 6 locations. 
In summary, time-resolved broadband measurements were performed on 53 subjects at 6 different bone prominence 
locations. The measured curves were primarily fitted for absorption values followed by a secondary fit to extract key 
tissue constituents. The plots depicting the fit to measured absorption values were plotted. The percentage key tissue 
constituents (water, lipid, collagen), oxy-,deoxy- hemoglobin (µM) along with scattering a and b values  were tabulated 
in a Table 1. Our future goal is to investigate the correlation of the tissue constituents data with the gold standard DEXA 
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data to explore the feasibility of using time-resolved diffuse optics as a tool for assessing bone related pathologies. Also,
bone marrow oxygenation and perfusion could be monitored16 in relation to physiological or pathological processes. 
Table 1: Quantified values of tissue constituents at the 6 locations 
Location
Hb 
[uM] 
HbO2
[uM] 
Lipid
[%] 
H2O 
[%] 
Collagen
[%] 
Background
[cm-1] 
tHb
[uM] 
StO2
[%] 
a
[cm-1] b
Trochanter 7.9 9.7 60.8% 21.9% 17.4% 0.00 17.7 55% 10.4 0.5
Radius 
Distal 0.6 27.7 55.8% 25.7% 18.5% 0.03 28.3 98% 8.3 0.6
Radius 
Proximal 0.3 18.9 54.4% 28.5% 17.1% 0.05 19.2 98% 8.4 0.5
Ulna 
Distal 2.2 23.1 65.1% 22.9% 12.0% 0.01 25.3 91% 3.8 1.3
Ulna 
Proximal 13.5 38.6 26.8% 42.7% 30.5% 0.02 52.0 74% 4.9 0.9
Calcaneous 9.5 11.0 68.3% 20.1% 11.6% 0.02 20.5 54% 11.7 0.4
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